Skip to content
OpenCapital
Get started

Organon OGN Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Organon's business combination, contingent consideration arrangements, change in amount of contingent consideration, asset?
Organon (OGN) reported business combination, contingent consideration arrangements, change in amount of contingent consideration, asset of $5M in Q1 2026.
How has Organon's business combination, contingent consideration arrangements, change in amount of contingent consideration, asset changed year-over-year?
Organon's business combination, contingent consideration arrangements, change in amount of contingent consideration, asset increased by 145.5% year-over-year, from -$11M to $5M.